(Q35202155)

7 August 2017

1 reference

title

Adjuvant therapy for rectal cancer--the transatlantic view (English)

1 reference

7 August 2017

Minsky BD

1

1 reference

7 August 2017

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

5

1 reference

7 August 2017

416-422

1 reference

7 August 2017

5

1 reference

Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study

7 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Preoperative staging of rectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Mesorectal excision for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Preoperative radiotherapy for resectable rectal cancer: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Acute Side Effects and Complications After Short-Term Preoperative Radiotherapy Combined With Total Mesorectal Excision in Primary Rectal Cancer: Report of a Multicenter Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

The accuracy of transrectal ultrasound in predicting the pathological stage of low-lying rectal cancer after preoperative chemoradiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Total mesenteric excision in the surgical treatment of rectal cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Mesorectal excision for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Effect of the introduction of total mesorectal excision for the treatment of rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

Changing strategy for rectal cancer is associated with improved outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1318.2003.00504.X

10.1046/J.1463-1318.2003.00504.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12925072